<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Supernus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company currently markets Trokendi XRÂŽ (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XRÂŽ (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-810 for the treatment of Impulsive Aggression in ADHD patients, SPN-812 for the treatment of ADHD and SPN-604 for the treatment of bipolar disorder. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jack A. Khattar
    • FOUNDED
      2005
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Ansell Ltd.

    Ansell Ltd.

    Ansell Limited provides health and safety protection solutions. The Company has op...

    Ansell Limited provides health and safety prote...

    Filing Type:    PR
    boon, Inc.

    boon, Inc.

    Boon, Inc. offers on-demand temporary dental, veterinary and medical staffing via ...

    Boon, Inc. offers on-demand temporary dental, v...

    Amount Raised:    $143,161
    Filing Type:    CF
    Repligen Corporation

    Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercia...

    Repligen Corporation is a global bioprocessing ...

    Filing Type:    PU
    Fulcrum Therapeutics, Inc.

    Fulcrum Therapeutics, Inc.

    We are a clinical-stage biopharmaceutical company focused on improving the lives o...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...

    Filing Type:    PU
    Trevena, Inc.

    Trevena, Inc.

    Trevena is a biopharmaceutical company focused on the development and commercializ...

    Trevena is a biopharmaceutical company focused ...

    Filing Type:    PU
    ACADIA Pharmaceuticals

    ACADIA Pharmaceuticals

    At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients w...

    At ACADIA (NASDAQ: ACAD), we share a passion fo...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.